Key stat: GLP-1 medications accounted for $360.9 million, or 35.7%, of the top 10 prescription linear TV ad spending in H1 2025, according to a July iSpot.tv report.

Beyond the chart:

• Nearly half (49%) of GLP-1 users pay more attention to food labels since starting the medication, according to a January Dentsu report.
• Over half of Gen Z (55.3%) and millennials (50.3%) who are aware of GLP-1s have seen their ads on social media, per a December EMARKETER survey.

Use this chart: Marketers can use this chart to align health messaging with surging demand for weight-loss treatments, and consider the value of TV ads even as the broader industry shifts digital.

Related EMARKETER reports:

• The Impact of Weight Loss Drugs 2025 (EMARKETER subscription required)
• Health Trends to Watch in 2025 (EMARKETER subscription required)

Note: Data was provided to EMARKETER by iSpot.tv.

Methodology: Data is from July 2025 iSpot.tv data provided to EMARKETER. Data reflects the estimated amount spent on national linear TV airings during Jan 1-June 30, 2025.